Home: Maucher Jenkins

Intellectual Property

Patents | Trade Marks | Designs

Supplementary Protection Certificates

SPCs can extend the length of patent protection in relation to particular pharmaceutical products, both human and veterinary, as well as plant protection.

A patent application would normally be filed at the initial stages of research and because medicinal products will undergo rigorous assessment and clinical trials before a marketing authorisation is finally granted, there is a risk that the patent expires before the pharmaceutical company has had time to make some return on its investment.

 

To compensate for the short effective life of a patent in this sector, most jurisdictions have provisions for supplementary protection certificates, which can extend the period of protection of a medicinal product for up to 5 years (or up to 5.5 years for paediatric medicinal products). This extension is a considerable asset, especially when relating to blockbuster drugs generating significant profits. 


Please contact our experts for more information:

Reuben Jacob, Dr. Fiona Kellas

Where would you like to go next?

C
This site uses cookies.

Some of these cookies are essential, while others help us to improve your experience by providing insights into how the site is being used. For more detailed information on the cookies we use, please check our Privacy Policy

Necessary Cookies

Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.

Analytical Cookies

Analytical cookies help us to improve our website by collecting and reporting information on its usage.

x